Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from LMND

MarketBeat Week in Review – 11/03 - 11/07

Stocks sold off this week with the tech-heavy NASDAQ index leading the way; this may be the start of a broader selloff; which could be a buying opportunity

MarketBeat

Should You Buy the Post-Earnings Pop in Lemonade Stock Today?

Lemonade stock soars as the AI-powered insurance firm reports a strong Q3 and raises future guidance. Here’s why LMND shares are worth buying into the post-earnings strength.

Barchart

Is Lemonade Stock Set for a Big Squeeze After Earnings?

Lemonade (NYSE: LMND) is up more than 60% year to date and consolidating just below its 52-week high, setting up a potential breakout ahead of its Q3 earnings.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Chamath Palihapitiya Returns To SPACs: Past 18 Deals, Investments Average Loss Of 14%

Investor Chamath Palihapitiya, once known as the "SPAC King," is back with a new SPAC, signaling a potential top or bottom for the SPAC market, with investors cautious after past returns from completed mergers.

Benzinga

Lemonade Delivers Sweet Results, Price Reversal to Accelerate

AI-powered insurance provider Lemonade is on track to reach profitability next year and may exceed forecasts in 2025 because of increasing leverage.

MarketBeat

Lemonade's Q4 Surge: Has This AI-Powered Insurer Turned a Corner?

Lemonade's strong earnings and AI-powered insurance model are fueling investor optimism, potentially signaling a shift toward sustained profitability.

MarketBeat

2 Small-Cap Stocks Insiders Are Buying This Month

Top company insiders have been buying shares of these two Russell 2000 Index components. Here's what investors need to know about these two stocks under $20.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Best men’s style boxers shorts for women

Take homme/femme fashion to the next level

Evening Standard

Berkshire Hathaway (BRK.B), Old Republic International (ORI), and Lemonade (LMND) -- Buy, Hold or Sell?

The insurance sector illustrates significant potential, particularly within the property and casualty segment. Given this backdrop, let us ascertain which insurance stocks among Lemonade (LMND), Berkshire Hathaway (BRK.B), and Old Republic International (ORI) are worth buying, selling, or holding. Read on….

StockNews.com

3 Stocks Causing MAJOR Casualties in Investors Portfolios

High inflation and rate hikes are gulping away the insurance industry’s profit. Moreover, recessionary fears following the turmoil in the banking sector have dampened the industry’s prospects this year. Hence, it could be wise to avoid fundamentally weak insurance stocks Lemonade (LMND), Hippo Holdings (HIPO), and Maiden Holdings (MHLD). Read…

StockNews.com

Should Lemonade Be in Your Portfolio This Summer?

Although insurance companies benefit from rising interest rates, Lemonade (LMND) failed to surpass the consensus EPS estimate in the last reported quarter. Analysts expect its EPS to remain negative in fiscal 2022 and 2023. So, will LMND be able to turn around in this rising interest rate environment? Read on…

StockNews.com

Insurtech Bet Lemonade Stock Is Low Enough to Buy Now

Lemonade (LMND) has been a post-IPO disappointment, but a unique joining of AI and insurance could produce a long-term winner.

StockNews.com

What 5 Analyst Ratings Have To Say About Lemonade

Within the last quarter, Lemonade (NYSE:LMND) has observed the following analyst ratings:

Benzinga

Lemonade vs. Root: Which Insurance Stock is a Better Choice?

Today I'll analyze Lemonade (LMND) and Root (ROOT) to determine which insurance stock is a better buy.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

2 Overvalued Insurance Stocks to Sell Right Now

A hawkish Fed bodes well for the financial sector, including the insurance industry. But despite favorable impending interest rate hikes, fundamentally bleak insurance stocks Trupanion, Inc. (TRUP) and Lemonade, Inc. (LMND) look overvalued at their current price levels. So, we think it could be wise to avoid these stocks. Read…

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Berkshire Hathaway Inc

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.